Human Recombinant GUCY2C protein, APC Conjugated, His Tag (V2LY-0526-LY4443)

Go to compare Compare Online Inquiry
Request for COA
Datasheet Target References Q & As Review & reward Protocols Associated Products

Basic Information

Expressed Host
HEK293 Cells
Protein Species
Human
Tag
His Tag
Protein Construction
This product is Human Recombinant GUCY2C protein, APC Conjugated, His Tag consist of Amino Acid: 1-430 and predicts a molecular mass of 49.8 kDa.
Molecule Mass
49.8 kDa
Conjugates
APC
Sequence
Amino Acid: 1-430
Species
Human

Formulations & Storage [For reference only, actual COA shall prevail!]

Endotoxin
Please contact us for more information.
Format
Lyophilized
Reconstitution
Allow the vial and reconstitution buffer to equilibrate to room temperature. Briefly centrifuge or tap down the vial to ensure that all lyophilized powder is collected at the bottom of the vial. For the reconstitution of this product, we recommend adding PBS or sterile water to achieve a final antibody concentration of 1 mg/mL. Allow the vial to reconstitute for 10-15 minutes at room temperature with gentle agitation. Avoid vigorous shaking that can cause foaming and antibody denaturation. Aliquot into volumes based on your experiment and store liquid protein at -20°C or -80°C for long time.
Buffer
Lyophilized from sterile PBS
Preservative
None
Storage
Twelve months from date of receipt at -20°C to -70°C in lyophilized form and 3 months at -70°C under sterile conditions after reconstitution. Protect from prolonged exposure to light and avoid repeated freeze-thaw cycles.
More Infomation

Target

Full Name
guanylate cyclase 2C (heat stable enterotoxin receptor)
Function
Guanylyl cyclase that catalyzes synthesis of cyclic GMP (cGMP) from GTP (PubMed:1718270, PubMed:11950846, PubMed:23269669, PubMed:22521417, PubMed:22436048).

Receptor for the E.coli heat-stable enterotoxin; E.coli enterotoxin markedly stimulates the accumulation of cGMP in mammalian cells expressing GUCY2C (PubMed:1718270, PubMed:1680854).

Also activated by the endogenous peptides guanylin and uroguanylin (PubMed:8381596).
Biological Process
cGMP biosynthetic process Source: GO_Central
Intracellular signal transduction Source: InterPro
Receptor guanylyl cyclase signaling pathway Source: GO_Central
Regulation of cell population proliferation Source: Ensembl
Response to toxic substance Source: Ensembl
Signal transduction Source: GO_Central
Cellular Location
Cell membrane; Endoplasmic reticulum membrane. The 145 kDa plasma membrane form of GUCY2C contains sialic acid and galactose residues, while a differencially glycosylated 130 Kda form is a high mannose form that is resident in the endoplasmic reticulum and may serve as the precursor for the cell surface form.
Involvement in disease
Diarrhea 6 (DIAR6):
A relatively mild, early-onset chronic diarrhea that may be associated with increased susceptibility to inflammatory bowel disease, small bowel obstruction, and esophagitis.
Meconium ileus (MECIL):
A condition characterized by intestinal obstruction due to inspissated meconium in the distal ileum and cecum, which develops in utero and presents shortly after birth as a failure to pass meconium. Meconium ileus is a known clinical manifestation of cystic fibrosis.
Topology
Extracellular: 24-430
Helical: 431-454
Cytoplasmic: 455-1073
PTM
Glycosylation at Asn-75 and/or Asn-79 is required for interaction with VIP36 while glycosylation at Asn-345 and Asn-402 modulates ligand-mediated GUCY2C activation.

Barton, J. R., Londregran, A. K., Alexander, T. D., Entezari, A. A., Bar-Ad, S., Cheng, L., ... & Waldman, S. A. (2023). Intestinal neuropod cell GUCY2C regulates visceral pain. The Journal of Clinical Investigation, 133(4).

Rappaport, J. A., Entezari, A. A., Caspi, A., Caksa, S., Jhaveri, A. V., Stanek, T. J., ... & Waldman, S. A. (2022). A β-catenin-TCF-sensitive locus control region mediates GUCY2C ligand loss in colorectal cancer. Cellular and Molecular Gastroenterology and Hepatology, 13(4), 1276-1296.

Lisby, A. N., Flickinger Jr, J. C., Bashir, B., Weindorfer, M., Shelukar, S., Crutcher, M., ... & Waldman, S. A. (2021). GUCY2C as a biomarker to target precision therapies for patients with colorectal cancer. Expert review of precision medicine and drug development, 6(2), 117-129.

Mishra, V., Bose, A., Kiran, S., Banerjee, S., Shah, I. A., Chaukimath, P., ... & Visweswariah, S. S. (2021). Gut-associated cGMP mediates colitis and dysbiosis in a mouse model of an activating mutation in GUCY2C. Journal of Experimental Medicine, 218(11).

van Vugt, A. H., Bijvelds, M. J., de Jonge, H. R., Meijsen, K. F., Restin, T., Bryant, M. B., ... & Middendorp, S. (2021). A potential treatment of congenital sodium diarrhea in patients with activating GUCY2C mutations. Clinical and Translational Gastroenterology, 12(11).

Jimenez-Luna, C., González-Flores, E., Ortiz, R., Martínez-González, L. J., Antúnez-Rodríguez, A., Expósito-Ruiz, M., ... & Prados, J. (2021). Circulating PTGS2, JAG1, GUCY2C and PGF mRNA in peripheral blood and serum as potential biomarkers for patients with metastatic colon cancer. Journal of Clinical Medicine, 10(11), 2248.

Mathur, D., Root, A. R., Bugaj-Gaweda, B., Bisulco, S., Tan, X., Fang, W., ... & Sapra, P. (2020). A Novel GUCY2C-CD3 T-Cell Engaging Bispecific Construct (PF-07062119) for the Treatment of Gastrointestinal CancersA GUCY2C-CD3 Bispecific Targets Gastrointestinal Cancers. Clinical Cancer Research, 26(9), 2188-2202.

Snook, A. E., Baybutt, T. R., Xiang, B., Abraham, T. S., Flickinger, J. C., Hyslop, T., ... & Waldman, S. A. (2019). Split tolerance permits safe Ad5-GUCY2C-PADRE vaccine-induced T-cell responses in colon cancer patients. Journal for ImmunoTherapy of Cancer, 7(1), 1-12.

Merlino, D. J., Barton, J. R., Charsar, B. A., Byrne, M. D., Rappaport, J. A., Smeyne, R. J., ... & Waldman, S. A. (2019). Two distinct GUCY2C circuits with PMV (hypothalamic) and SN/VTA (midbrain) origin. Brain Structure and Function, 224, 2983-2999.

Magee, M. S., Abraham, T. S., Baybutt, T. R., Flickinger Jr, J. C., Ridge, N. A., Marszalowicz, G. P., ... & Snook, A. E. (2018). Human GUCY2C-targeted chimeric antigen receptor (CAR)-expressing T cells eliminate colorectal cancer metastases. Cancer immunology research, 6(5), 509-516.

Ask a question We look forward to hearing from you.
0 reviews or Q&As
Loading...
Have you used Human Recombinant GUCY2C protein, APC Conjugated, His Tag?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon $30 eGift Card
Submit a review
Loading...
For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Contact us

  • Tel: (USA)
  • (UK)
  • Fax:
  • Email:

Submit A Review

online inquiry
Online Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.